Viral Orchitis – A Complete Patient Guide

Overview

Orchitis is inflammation of one or both testes. When the inflammation is caused by a virus, the condition is called viral orchitis. It is most often associated with viral infections that also affect the upper respiratory tract, such as mumps, but other viruses (e.g., coxsackie, Epstein‑Barr, HIV) can be involved.

Who it affects: The condition can occur at any age, but it is most common in males aged 15‑30 years, largely because this is the age group most likely to contract mumps and other respiratory viruses. In the United States, viral orchitis accounts for roughly 30–40 % of all orchitis cases, with mumps orchitis representing the majority of those cases.^{[1] CDC, 2023}

Prevalence: Worldwide, an estimated 5–10 % of post‑pubertal males who contract mumps develop orchitis, whereas the rate in pre‑pubertal boys is <1 %.^{[2] WHO, 2022} In regions with high mumps vaccination coverage, the overall incidence has fallen dramatically, yet outbreaks still occur in under‑immunized populations.

Symptoms

Symptoms typically appear 1–3 weeks after the initial viral illness and may affect one or both testes.

• Pain or tenderness in the scrotum – often sudden, sharp, and can radiate to the groin or lower abdomen.
• Swelling of the affected testis (or both), which can make the scrotum feel heavy.
• Redness or warmth of the scrotal skin.
• Fever (usually low‑grade, < 38 °C/100.4 °F) accompanying the testicular pain.
• Headache, malaise, and myalgias – typical of a systemic viral infection.
• Epididymal involvement – pain may extend to the epididymis (the tube behind the testis), leading to epididymo‑orchitis.
• Urinary symptoms (less common) – dysuria or increased frequency if the infection spreads to nearby structures.
• Infertility signs – rarely, patients notice reduced fertility after repeated episodes.

Symptoms usually resolve within 1–2 weeks, but persistent pain beyond 3 weeks warrants further evaluation.

Causes and Risk Factors

Viral Etiology

• Mumps virus (Paramyxovirus) – the classic cause; orchitis follows parotitis in ~30 % of post‑pubertal males.^[1]
• Coxsackievirus – can cause a hand‑foot‑mouth‑like illness with secondary testicular involvement.
• Epstein‑Barr virus (EBV) – occasionally linked to orchitis during infectious mononucleosis.
• Human immunodeficiency virus (HIV) – chronic infection may cause orchitis as part of opportunistic disease.
• Other respiratory viruses (e.g., influenza, adenovirus) – rare but reported in case series.

Risk Factors

• Age 15‑30 years – peak incidence of mumps orchitis.
• Unvaccinated or incompletely vaccinated status – especially against mumps.
• Close contact with infected individuals – household or dormitory settings.
• Immunocompromised state – HIV, chemotherapy, or chronic steroid use increase susceptibility.
• History of prior orchitis or epididymitis – may predispose to recurrent inflammation.

Diagnosis

Diagnosis is mainly clinical, supported by laboratory and imaging studies to rule out bacterial infection or other scrotal pathology.

History and Physical Examination

• Recent viral illness (e.g., mumps, pharyngitis) + onset of scrotal pain.
• Inspection for erythema, swelling, or asymmetry.
• Palpation – painful, tender testes; distinguish from torsion (sudden onset, high‑riding testis).

Laboratory Tests

• Complete blood count (CBC) – may show mild leukocytosis.
• C‑reactive protein (CRP) / ESR – elevated in inflammation but non‑specific.
• Viral serology – IgM/IgG for mumps, coxsackie, EBV if diagnosis is uncertain.
• Urinalysis – to exclude urinary tract infection or sexually transmitted disease.
• PCR testing – nasopharyngeal swab for mumps virus during outbreak settings.

Imaging

• Scrotal ultrasonography (high‑frequency) – first‑line imaging. Findings in viral orchitis include:
  • Enlarged, hypoechoic testis.
  • Increased blood flow on Doppler (hyperemia).
  • Absence of abscess or focal collections (helps differentiate from bacterial abscess).
• Color Doppler ultrasound – distinguishes orchitis (increased flow) from torsion (decreased/absent flow).

Differential Diagnosis

Physicians must rule out:

• Bacterial epididymo‑orchitis.
• Testicular torsion (surgical emergency).
• Testicular tumor (especially if mass persists after inflammation resolves).
• Hydrocele or varicocele.

Treatment Options

Because viruses are not directly susceptible to antibiotics, management focuses on symptom control, preventing complications, and addressing any secondary bacterial infection.

Medications

• Pain relief – acetaminophen or ibuprofen (400–600 mg every 6–8 h) is first‑line.^{[3] Mayo Clinic, 2024}
• Cold packs – applied for 15‑20 minutes, several times daily, to reduce swelling.
• Antibiotics – only if bacterial superinfection is suspected (e.g., positive urine culture). Typical regimens: doxycycline 100 mg BID × 10 days or ceftriaxone IM followed by oral cefixime.
• Antivirals – no specific antiviral for mumps; experimental therapies (e.g., ribavirin) have not shown consistent benefit.
• Corticosteroids – occasionally used for severe inflammation, but evidence is limited; usually reserved for refractory cases under specialist guidance.

Procedures

• Scrotal support – wear an athletic supporter or snug underwear to decrease motion‑induced pain.
• Drainage – rarely required; indicated only if a secondary bacterial abscess forms.
• Surgical exploration – indicated when torsion cannot be excluded, or when a suspicious mass persists after inflammation resolves.

Lifestyle and Self‑Care

• Rest and avoid strenuous activity or heavy lifting for 1–2 weeks.
• Stay well‑hydrated; adequate fluid intake aids systemic recovery.
• Maintain genital hygiene – gentle cleaning with mild soap, avoid irritants.
• Consider over‑the‑counter scrotal support devices available at pharmacies.

Living with Viral Orchitis

Daily Management Tips

• Pain diary – record pain intensity (0–10 scale) and triggers to discuss with your provider.
• Temperature monitoring – check twice daily; persistent fever >38.5 °C for >48 h warrants re‑evaluation.
• Scrotal elevation – lie on your back with a rolled towel under the scrotum to reduce venous congestion.
• Gentle exercise – after acute pain subsides, short walks help circulation; avoid cycling or running until pain resolves.
• Sexual activity – pause until discomfort fully resolves (usually 2‑3 weeks) to prevent further irritation.

Follow‑up Care

Schedule a follow‑up visit 1–2 weeks after symptom onset for repeat ultrasound if pain persists, to ensure resolution and to rule out complications such as testicular atrophy.

Prevention

• Vaccination – the MMR (measles‑mumps‑rubella) vaccine provides >95 % protection against mumps. Two doses are recommended for children and adolescents; adults lacking documented immunity should receive at least one dose.^{[4] CDC, 2024}
• Hand hygiene – frequent hand washing with soap for at least 20 seconds, especially after coughing or sneezing.
• Avoid close contact with individuals who have active respiratory infections; maintain distance during outbreaks.
• Respiratory etiquette – cover mouth/nose with tissue or elbow when coughing/sneezing.
• Boost immune health – balanced diet, regular sleep, and moderate exercise reduce susceptibility to viral infections.

Complications

While most cases resolve without lasting effects, untreated or severe viral orchitis can lead to:

• Testicular atrophy – shrinkage of the testis, which may reduce hormone production and sperm output.
• Infertility – especially after bilateral involvement or recurrent episodes.
• Chronic scrotal pain – lasting >3 months, often requiring pain‑management specialist referral.
• Secondary bacterial infection – can progress to abscess formation.
• Psychological distress – anxiety about sexual function or fertility.

Early recognition and appropriate care dramatically lower the risk of these outcomes.

When to Seek Emergency Care

---

Sources: [1] Centers for Disease Control and Prevention. “Mumps (MMR) Vaccine.” 2023.
[2] World Health Organization. “Mumps Fact Sheet.” 2022.
[3] Mayo Clinic. “Orchitis: Symptoms and Treatment.” Updated 2024.
[4] CDC. “MMR Vaccine Recommendations.” 2024.
Additional references: National Institutes of Health (NIH) – MedlinePlus, Cleveland Clinic.